FDG-PET

¹⁸F-Fluorodeoxyglucose-Positron Emission Tomography and Pathologic Tumor Size in Early-Stage Invasive Cervical Cancer
Timothy N. Showalter, Tom R. Miller, Phyllis Huettner, Janet Rader, Perry W. Grigsby

International Journal of Gynecologic Cancer Nov 2009, 19 (8) 1412-1414; DOI: 10.1111/IGC.0b013e3181b62e8c
Gene expression patterns in advanced human cervical cancer
P. W. Grigsby, M. Watson, M. A. Powell, Z. Zhang, J. S. Rader

International Journal of Gynecologic Cancer Mar 2006, 16 (2) 562-567; DOI: 10.1136/ijgc-00009577-200603000-00015
Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas
M. Murakami, H. Tsukada, M. Shida, M. Watanabe, H. Maeda, S. Koido, T. Hirasawa, T. Muramatsu, T. Miyamoto, S. Nasu, S. Yasuda, H. Kajiwara, M. Yasuda, M. Ide

International Journal of Gynecologic Cancer Mar 2006, 16 (2) 854-860; DOI: 10.1136/ijgc-00009577-200603000-00062
Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer
R. Suzuki, E. Miyagi, N. Takahashi, A. Sukegawa, A. Suzuki, I. Koike, K. Sugiura, N. Okamoto, T. Inoue, F. Hirahara

International Journal of Gynecologic Cancer Jul 2007, 17 (4) 890-896; DOI: 10.1136/ijgc-00009577-200707000-00021

Main menu